These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2675485)
1. Structural similarity of the type-specific group B streptococcal polysaccharides and the carbohydrate units of tissue glycoproteins: evaluation of possible cross-reactivity. Häyrinen J; Pelkonen S; Finne J Vaccine; 1989 Jun; 7(3):217-24. PubMed ID: 2675485 [TBL] [Abstract][Full Text] [Related]
2. Immunoblot analysis of bacterial polysaccharides: application to the type-specific polysaccharides of Streptococcus suis and Streptococcus agalactiae. Tikkanen K; Häyrinen J; Pelkonen S; Finne J J Immunol Methods; 1995 Dec; 187(2):233-44. PubMed ID: 7499882 [TBL] [Abstract][Full Text] [Related]
3. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines. Colling RG; Pearson TC; Brown JC Infect Immun; 1983 Jul; 41(1):205-13. PubMed ID: 6345390 [TBL] [Abstract][Full Text] [Related]
4. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276 [TBL] [Abstract][Full Text] [Related]
5. Distribution of B streptococcal type antigens among streptococci of serological groups B, G and L. Wibawan IW; Lämmler C Zentralbl Bakteriol; 1990 Sep; 273(4):471-7. PubMed ID: 2123387 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera. Fischer GW; Lowell GH; Crumrine MH; Bass JW J Exp Med; 1978 Sep; 148(3):776-86. PubMed ID: 29937 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. Kasper DL; Baker CJ; Galdes B; Katzenellenbogen E; Jennings HJ J Clin Invest; 1983 Jul; 72(1):260-9. PubMed ID: 6192144 [TBL] [Abstract][Full Text] [Related]
8. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera. Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816 [TBL] [Abstract][Full Text] [Related]
9. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide. De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM Infect Immun; 1982 Sep; 37(3):961-5. PubMed ID: 6752032 [TBL] [Abstract][Full Text] [Related]
10. [Serologic cross reactions of group B streptococci]. Uhlenbruck G; Lütticken R; Bäz K; Böhmer G Immun Infekt; 1985 Nov; 13(6):276-82. PubMed ID: 2416673 [TBL] [Abstract][Full Text] [Related]
11. Immunodeterminant specificity of human immunity to type III group B streptococcus. Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042 [TBL] [Abstract][Full Text] [Related]
12. Serologic cross-reactions among streptococcal group A, A-variant, and C polysaccharides. Shulman ST; Ayoub EM Clin Immunol Immunopathol; 1983 Aug; 28(2):229-42. PubMed ID: 6872361 [TBL] [Abstract][Full Text] [Related]
13. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105 [TBL] [Abstract][Full Text] [Related]
14. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. Madoff LC; Paoletti LC; Tai JY; Kasper DL J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832 [TBL] [Abstract][Full Text] [Related]
15. Interaction of group B streptococcal type-specific polysaccharides with wheat germ agglutinin and other lectins. Gray BM; Dillon HC; Pritchard DG J Immunol Methods; 1984 Aug; 72(1):269-77. PubMed ID: 6205097 [TBL] [Abstract][Full Text] [Related]
16. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Baker CJ; Webb BJ; Kasper DL; Yow MD; Beachler CW Am J Obstet Gynecol; 1980 May; 137(1):39-42. PubMed ID: 6989248 [TBL] [Abstract][Full Text] [Related]
17. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045 [TBL] [Abstract][Full Text] [Related]
18. Group B streptococcus type II antisera have anti-galactan specificities. Uhlenbruck G; Lütticken R; Böhmer G; Janssen E; Pulverer G Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):179-87. PubMed ID: 3925659 [TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes. Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909 [TBL] [Abstract][Full Text] [Related]
20. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. Baker CJ; Kasper DL N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]